Alzheimer’s patient brain myeloid cells exhibit enhanced aging and unique transcriptional activation

Abstract

Gene expression changes in brain microglia from mouse models of Alzheimer’s disease (AD) are highly characterized and reflect specific myeloid cell activation states that could modulate AD risk or progression. While some groups have produced valuable expression profiles for human brain cells1–4, the cellular clarity with which we now view transcriptional responses in mouse AD models has not yet been realized for human AD tissues due to limited availability of fresh tissue samples and technological hurdles of recovering transcriptomic data with cell-type resolution from frozen samples. We developed a novel method for isolating multiple cell types from frozen post-mortem specimens of superior frontal gyrus for RNA-Seq and identified 66 genes differentially expressed between AD and control subjects in the myeloid cell compartment. Myeloid cells sorted from fusiform gyrus of the same subjects showed similar changes, and whole tissue RNA analyses further corroborated our findings. The changes we observed did not resemble the “damage-associated microglia” (DAM) profile described in mouse AD models5, or other known activation states from other disease models. Instead, roughly half of the changes were consistent with an “enhanced human aging” phenotype, whereas the other half, including the AD risk gene APOE, were altered in AD myeloid cells but not differentially expressed with age. We refer to this novel profile in human Alzheimer’s microglia/myeloid cells as the HAM signature. These results, which can be browsed at research-pub.gene.com/BrainMyeloidLandscape/reviewVersion, highlight considerable differences between myeloid activation in mouse models and human disease, and provide a genome-wide picture of brain myeloid activation in human AD.

Molecular characterization of selectively vulnerable neurons in Alzheimer’s Disease

“…Next, we asked whether a specific transcriptional state of microglia is associated with AD in our dataset. Recent single-cell profiling of microglia from mouse models of AD identified disease-associated microglia 44 (DAM), the transcriptional signature of which overlap only partially with that of human microglia found in AD 45 . Considering the possibility that DAMs may cluster separately from homeostatic microglia after cross-sample alignment, we performed subclustering of microglia in our dataset, discerning 4 subpopulations in the EC and 5 subpopulations in the SFG (Extended Data Fig.…”

Discovery of autism/intellectual disability somatic mutations in Alzheimer's brains: mutated ADNP cytoskeletal impairments and repair as a case study

“…To better understand the cellular distribution of the mutations, an additional database was mined GSE125050 [42] (Fig. 3c-e, Table S12 a, b).…”

Spatial and temporal transcriptomics reveal microglia-astroglia crosstalk in the amyloid-β plaque cell niche of Alzheimer’s disease

“…Tremendous progress has been made over the last years to define cell states in physiological and pathological conditions using next generation sequencing approaches. For example, in the Alzheimer' disease (AD) field, we know now that microglia respond with a stereotypical response to amyloid-β (Aβ) plaque formation (Keren-Shaul et al, 2017;Krasemann et al, 2017;Sala Frigerio et al, 2019;Srinivasan et al, 2019). Less is however known about neurons, astrocytes or oligodendrocytes.…”